DrugPatentWatch Database Preview
ADAPALENE AND BENZOYL PEROXIDE Drug Profile
» See Plans and Pricing
When do Adapalene And Benzoyl Peroxide patents expire, and when can generic versions of Adapalene And Benzoyl Peroxide launch?
Adapalene And Benzoyl Peroxide is a drug marketed by Actavis Mid Atlantic, Glenmark Pharms Ltd, Perrigo Uk Finco, Taro, and Tolmar. and is included in six NDAs.
The generic ingredient in ADAPALENE AND BENZOYL PEROXIDE is adapalene; benzoyl peroxide. There are twelve drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the adapalene; benzoyl peroxide profile page.
Summary for ADAPALENE AND BENZOYL PEROXIDE
US Patents: | 0 |
Applicants: | 5 |
NDAs: | 6 |
Suppliers / Packagers: | 4 |
Clinical Trials: | 38 |
Formulation / Manufacturing: | see details |
DailyMed Link: | ADAPALENE AND BENZOYL PEROXIDE at DailyMed |

Recent Clinical Trials for ADAPALENE AND BENZOYL PEROXIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Mahidol University | Phase 2 |
Beiersdorf | Phase 2 |
New York University School of Medicine | N/A |
Pharmacology for ADAPALENE AND BENZOYL PEROXIDE
Drug Class | Retinoid |